Medical

Palatin Targets the Next Generation of Rare Obesity Therapies After MC4R Validation (NASDAQ: PTN)

WSW, NY, 28th September 2026, FinanceWire … Read More

YEARS Marks Two Years Since Clinic Opening and Expands Capacity by 50%

Berlin, Germany, 28th September 2026, FinanceWire … Read More

Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead Asset

WSW, NY, 25th September 2026, FinanceWire … Read More

Forex Expo Dubai 2026 Breaks Guinness World Record Again With 23,816 Attendees

Dubai, UAE, 24th September 2026, FinanceWire … Read More

Entera Bio Receives New Overweight Rating From Cantor Fitzgerald (NASDAQ: ENTX)

WSW, NY, 23rd September 2026, FinanceWire … Read More

Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD)

WSW, NY, 22nd September 2026, FinanceWire … Read More

Entera Receives $9 Price Target and New ‘Outperform’ Rating From Leerink Partners (NASDAQ: ENTX)

WSW, NY, 18th September 2026, FinanceWire … Read More

IR-MED and Dice Technologies Announce collaboration to Evaluate and Advance Pressure-Injury Prevention Platform in Japan

Rosh Pinna, Israel, 16th September 2026, FinanceWire … Read More

Alpha Tau’s Cancer Trials Keep Beating Expectations. Three Major Data Readouts Are Next.

WSW, NY, 15th September 2026, FinanceWire … Read More

GLP-1s Transformed Obesity. Billions Are Now Moving Into Rare Diseases That Require a Different Approach.

WSW, NY, 15th September 2026, FinanceWire … Read More